Cresco Labs (CRLBF) Cash from Investing Activities (2019 - 2025)
Cresco Labs (CRLBF) reported Cash from Investing Activities of -$13.2 million for Q4 2025, down 339.5% on a YoY basis from $5.5 million in Q4 2024, and down 116.23% quarter-over-quarter from -$6.1 million in Q3 2025.
Cresco Labs (CRLBF) Cash from Investing Activities (2019 - 2025) Analysis & Trends
Cresco Labs has reported Cash from Investing Activities for 7 years, with the latest figure at -$13.2 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities fell 339.5% year-over-year to -$13.2 million; the trailing twelve-month figure through Dec 2025 stood at -$28.6 million (down 49.61% YoY), and the FY2025 full-year result was -$40.7 million, down 61.34% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$13.2 million, down from -$6.1 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $23.5 million in Q3 2022, with the low at -$64.1 million in Q4 2021.
- Historically, Cash from Investing Activities has averaged -$16.0 million across 5 years, with a median of -$12.5 million in 2022.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities tumbled 581.77% — and 2022, when it soared 154.05%.
- Cresco Labs' Cash from Investing Activities stood at -$64.1 million in 2021, then surged by 80.57% to -$12.5 million in 2022, then surged by 120.95% to $2.6 million in 2023, then sank by 215.48% to -$3.0 million in 2024, then sank by 339.5% to -$13.2 million in 2025.
- The last three Cash from Investing Activities figures came in at -$13.2 million (Q4 2025), -$6.1 million (Q3 2025), and -$3.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.24 Mn |
| Dec 31, 2025 | -13.24 Mn |
| Sep 30, 2025 | -6.12 Mn |
| Sep 30, 2025 | -6.12 Mn |
| Dec 31, 2024 | -3.01 Mn |
| Dec 31, 2024 | -3.01 Mn |
| Sep 30, 2024 | -6.27 Mn |
| Sep 30, 2024 | -6.27 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Sep 30, 2023 | -12.48 Mn |
| Sep 30, 2023 | -12.48 Mn |
| Dec 31, 2022 | -12.45 Mn |
| Dec 31, 2022 | -12.45 Mn |
| Sep 30, 2022 | 23.48 Mn |
| Sep 30, 2022 | 23.48 Mn |
| Dec 31, 2021 | -64.11 Mn |
| Dec 31, 2021 | -64.11 Mn |
| Sep 30, 2021 | -43.45 Mn |
| Sep 30, 2021 | -43.45 Mn |